SEC EDGAR filings, ownership reports, and insider transactions for Apimeds Pharmaceuticals US, Inc..
Recent SEC filings for Apimeds Pharmaceuticals US, Inc. including PREM14C, 8-K, 8-K/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| PREM14C | Open PREM14C document | Open XBRL data | View SEC filing for PREM14C | INFORMATION STATEMENT | 16 Jan 2026 | 16 Jan 2026 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 02 Jan 2026 | 30 Dec 2025 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 10 Dec 2025 | 05 Dec 2025 | 001-42545 |
| 8-K/A | Open 8-K/A document | Open XBRL data | View SEC filing for 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 10 Dec 2025 | 01 Dec 2025 | 001-42545 |
| 425 | Open 425 document | View SEC filing for 425 | CURRENT REPORT | 02 Dec 2025 | 001-42545 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 02 Dec 2025 | 01 Dec 2025 | 001-42545 |
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 21 Nov 2025 | 12 May 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 18 Nov 2025 | 13 Nov 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 12 Nov 2025 | 30 Sep 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Oct 2025 | 15 Oct 2025 | 001-42545 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 19 Aug 2025 | 30 Jun 2025 | 001-42545 |
| NT 10-Q | Open NT 10-Q document | View SEC filing for NT 10-Q | NOTIFICATION OF LATE FILING | 14 Aug 2025 | 30 Jun 2025 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Jul 2025 | 15 Jul 2025 | 001-42545 |
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 11 Jun 2025 | 12 May 2025 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | PRIMARY DOCUMENT | 11 Jun 2025 | 04 Mar 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 05 Jun 2025 | 30 May 2025 | 001-42545 |
| S-8 | Open S-8 document | View SEC filing for S-8 | REGISTRATION STATEMENT | 23 May 2025 | 333-287564 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 20 May 2025 | 16 May 2025 | 001-42545 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 20 May 2025 | 31 Mar 2025 | 001-42545 |
| SCHEDULE 13D | Open SCHEDULE 13D document | Open XBRL data | View SEC filing for SCHEDULE 13D | 19 May 2025 | 005-95043 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 May 2025 | 13 May 2025 | |
| NT 10-Q | Open NT 10-Q document | View SEC filing for NT 10-Q | NOTIFICATION OF LATE FILING | 15 May 2025 | 31 Mar 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 May 2025 | 12 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 May 2025 | 12 May 2025 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | PRIMARY DOCUMENT | 14 May 2025 | 04 Mar 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 12 May 2025 | 08 May 2025 | 001-42545 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 09 May 2025 | 333-282324 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 05 May 2025 | 333-282324 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 May 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 May 2025 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 05 May 2025 | 001-42545 | ||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 02 May 2025 | 333-282324 | |
| 10-K/A | Open 10-K/A document | Open XBRL data | View SEC filing for 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 02 May 2025 | 31 Dec 2024 | 001-42545 |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 01 May 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 01 May 2025 | |||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 01 May 2025 | 333-282324 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 May 2025 | 001-42545 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 30 Apr 2025 | 333-282324 | ||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 17 Apr 2025 | 333-282324 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | ANNUAL REPORT | 15 Apr 2025 | 31 Dec 2024 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 15 Apr 2025 | 11 Apr 2025 | 001-42545 |
| NT 10-K | Open NT 10-K document | View SEC filing for NT 10-K | NOTIFICATION OF LATE FILING | 31 Mar 2025 | 31 Dec 2024 | 001-42545 |
| CERT | Open CERT document | View SEC filing for CERT | NYSE AMERICAN CERTIFICATION | 04 Mar 2025 | 001-42545 | |
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 03 Mar 2025 | 001-42545 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 11 Feb 2025 | 333-282324 | ||
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 10 Feb 2025 | 333-282324 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 10 Feb 2025 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 10 Feb 2025 | 333-282324 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 07 Feb 2025 | 377-07074 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 07 Feb 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 07 Feb 2025 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 06 Feb 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 29 Jan 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 10 Jan 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 20 Dec 2024 | 333-282324 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 19 Dec 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 16 Dec 2024 | 377-07074 | ||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 09 Dec 2024 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 08 Nov 2024 | 333-282324 | |
| S-1 | Open S-1 document | View SEC filing for S-1 | REGISTRATION STATEMENT | 25 Sep 2024 | 333-282324 | |
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 05 Aug 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 02 Aug 2024 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 17 Jun 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 14 Jun 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 May 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 13 May 2024 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 13 May 2024 | 377-07074 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 26 Feb 2024 | 377-07074 | ||
| DRS | Open DRS document | View SEC filing for DRS | 29 Jan 2024 | 377-07074 |
Apimeds Pharmaceuticals US, Inc. files with the SEC under CIK 0001894525. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.